A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration

British Journal of Ophthalmology

Volumn 92, Issue 6, 2008, Pages 757-761

  Odergren, A ^a   Algvere, P V ^a   Seregard, S ^a   Kvanta, A ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETREATMENT; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; THICKNESS; TRANSPUPILLARY THERMOTHERAPY; VISUAL ACUITY;

AGED; CHI-SQUARE DISTRIBUTION; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PORPHYRINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 45449107642     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.133561     Document Type: Article

References (25)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with Verteprofin. Two-year results of two randomized clinical trials. TAP Report 2. Arch Ophthalmol 2001;119:198-207.
2. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularisation. Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol 2001;131:541-60.
3. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Groups. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without Verteporfin therapy for choroidal neovascularization secondary to age-rearted macular degeneration: TAP and VIP Report No. 1. Am J Ophthalmol 2003;136:407-18.
4. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis and heat shock proteins. Ophthalmic Surg Lasers 2000;31:359-73.
5. Reichel E, Berrocal AM, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularisation in patients with age-related macular degeneration. Ophthalmology 1999;106:1908-14.
6. Algvere PV, Libert C, Seregard S. Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration. Semin Ophthalmol 2001;16:90-6.
7. Algvere PV, Libert C, Lindgärde G, et al. Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003;81:110-17.
8. Thach AB, Sipperley JO, Dugel PU, et al. Large-spot size transpupillary thermotherapy for the treatment of occult choroidal neovascularisation associated with age-related macular degeneration. Arch Ophthalmol 2003;121:817-20.
9. Stolba U, Krebs I, Lamar P, et al. Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trial. Br J Ophthalmol 2006;90:158-61.
10. Reichel E, Musch DC, Blodi BA, et al. Results from the TTT4CNV clinical trial. Invest Ophthalmol Vis Sci 2005 ARVO abstract 2311.
11. Ming Y, Algvere PV, Odergren A, et al. Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularisation in the mouse without collateral damage to the neural retina. Invest Ophthalmol Vis Sci 2004;45:1969-74.
12. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
13. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
14. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
15. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis and heat shock proteins. Ophthalmic Surg Lasers 2000;31:359-73.
16. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: Principles and techniques. Semin Ophthalmol 2001;16:55-9.
17. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113:810-18.
18. Zacks DN, Ezra E, Terada Y, et al. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterizaton. Invest Ophthalmol Vis Sci 2002;43:2384-91.
19. Odergren A, Ming Y, Kvanta A. Photodynamic therapy of experimental choroidal neovascularization in the mouse. Curr Eye Res 2006;31:765-74.
20. Schmidt-Erfurth U, Laqua H, Schlötzer-Schrehard U, et al. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 2002;120:835-43.
21. Lanzetta P, Michieletto P, Pirracchio A, et al. Early vascular changes induced by transpupillary thermotherapy of choroidal neovascularisation. Ophthalmology 2002;109:1098-104.
22. Slakter JS, Bochow TW, D'Amico DJ, et al. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology 2006;113:3-13.
23. Heier JS, Boyer DS, Ciulla TA, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Ach Ophthalmol 2006;124:1532-42.
24. Lazic R, Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Ophthalmology 2007;114:1179-85.
25. Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Graefes Arch Clin Exp Ophthalmol 2007;245:1273-80.